CNS Pharmaceuticals, Inc. - CNSP
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | History | New | 48,827 | 256 | 0.19% | — | 1 | +48,827 | New | Q4 2025 | Feb 13, 2026 |
| Ikarian Capital, LLC | History | New | 45,830 | 240 | 0.02% | — | 2 | +45,830 | New | Q4 2025 | Feb 18, 2026 |
| DRW Securities, LLC | History | Added to | 15,429 | 81 | 0.0% | 0.0% | 3 | +1,379 | 9.81% | Q4 2025 | Feb 12, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | History | New | 13,524 | 71 | 0.0% | — | 4 | +13,524 | New | Q4 2025 | Feb 17, 2026 |
| UBS Group AG | History | Reduced | 611 | 3 | 0.0% | 0.0% | 5 | -9,909 | -94.19% | Q4 2025 | Jan 29, 2026 |
| MORGAN STANLEY | History | Closed out | 0 | 0 | — | — | — | -28 | -100.0% | Q4 2025 | May 27, 2026 |
| Sound Income Strategies, LLC | History | New | 16 | 0 | — | — | — | +16 | New | Q4 2025 | Jan 21, 2026 |
| CITIGROUP INC | History | Closed out | 0 | 0 | — | — | — | -2 | -100.0% | Q4 2025 | Feb 13, 2026 |
| BANK OF AMERICA CORP /DE/ | History | No change | 4 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Feb 17, 2026 |
| DANSKE BANK A/S | History | No change | 1 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Feb 02, 2026 |
| BARRETT & COMPANY, INC. | History | No change | 8 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Jan 28, 2026 |
| MAI Capital Management | History | No change | 3 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Feb 13, 2026 |